Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTEL CORPORATION

(INTC)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-01 pm EST
29.07 USD   +2.87%
04:27aInfineon Shares Jump on Better-Than-Expected Guidance
DJ
02:34aInfineon 1Q Revenue Increased Amid Strong Automotive, Industrial Demand -- Update
DJ
02/01U.S. investors have plowed billions into China's AI sector, report shows
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

China's Xi unwilling to accept vaccines despite threat from protests-U.S. intel

12/04/2022 | 01:44am EST

WASHINGTON, Dec 3 (Reuters) - Chinese leader Xi Jinping is unwilling to accept Western vaccines despite the challenges China is facing with COVID-19, and while recent protests there are not a threat to Communist Party rule, they could affect his personal standing, U.S. Director of National Intelligence Avril Haines said on Saturday.

Although China's daily COVID cases are near all-time highs, some cities are taking steps to loosen testing and quarantine rules after Xi's zero-COVID policy triggered a sharp economic slowdown and public unrest.

Haines, speaking at the annual Reagan National Defense Forum in California, said that despite the social and economic impact of the virus, Xi "is unwilling to take a better vaccine from the West, and is instead relying on a vaccine in China that's just not nearly as effective against Omicron."

"Seeing protests and the response to it is countering the narrative that he likes to put forward, which is that China is so much more effective at government," Haines said.

"It's, again, not something we see as being a threat to stability at this moment, or regime change or anything like that," she said, while adding: "How it develops will be important to Xi's standing."

China's foreign ministry did not immediately respond to a request for comment sent on Sunday.

China has not approved any foreign COVID vaccines, opting for those produced domestically, which some studies have suggested are not as effective as some foreign ones. That means easing virus prevention measures could come with big risks, according to experts.

China had not asked the United States for vaccines, the White House said earlier in the week.

One U.S. official told Reuters there was "no expectation at present" that China would approve western vaccines.

"It seems fairly far-fetched that China would greenlight Western vaccines at this point. It's a matter of national pride, and they'd have to swallow quite a bit of it if they went this route," the official said.

Haines also said North Korea recognized that China was less likely to hold it accountable for what she said was Pyongyang's "extraordinary" number of weapons tests this year.

Amid a record year for missile tests, North Korean leader Kim Jong Un said last week his country intends to have the world's most powerful nuclear force.

Speaking on a later panel, Admiral John Aquilino, the commander of the U.S. Indo-Pacific Command, said China had no motivation to restrain any country, including North Korea, that was generating problems for the United States.

"I'd argue quite differently that it's in their strategy to drive those problems," Aquilino said of China.

He said China had considerable leverage to press North Korea over its weapons tests, but that he was not optimistic about Beijing "doing anything helpful to stabilize the region." (Reporting by Michael Martina, David Brunnstrom, Idrees Ali, and Eric Beech; Additional reporting by Martin Quin Pollard in Beijing; Editing by Sandra Maler and Lincoln Feast)


ę Reuters 2022
All news about INTEL CORPORATION
04:27aInfineon Shares Jump on Better-Than-Expected Guidance
DJ
02:34aInfineon 1Q Revenue Increased Amid Strong Automotive, Industrial Demand -- Update
DJ
02/01U.S. investors have plowed billions into China's AI sector, report shows
RE
02/01Intel, UC San Diego to Join US Program to Prevent Cyberattacks
MT
02/01Global markets live: AMD, Amgen, Electronic Arts, PayPal, Snap...
MS
02/01Intel and UC San Diego Join DARPA Program to Prevent Exploitation of Computing Systems
BU
02/01AMD shares jump as earnings defy collapse seen at Intel
RE
02/01Intel Enacts Broad Pay Cuts, Lowers CEO's Salary by 25%
MT
02/01Intel Cutting Pay for CEO, Management, and Senior Leaders
MT
02/01Futures dip on jitters ahead of ADP report, Fed decision
RE
More news
Analyst Recommendations on INTEL CORPORATION
More recommendations
Financials (USD)
Sales 2023 50 787 M - -
Net income 2023 -2 620 M - -
Net Debt 2023 25 584 M - -
P/E ratio 2023 -47,7x
Yield 2023 5,07%
Capitalization 120 B 120 B -
EV / Sales 2023 2,87x
EV / Sales 2024 2,66x
Nbr of Employees 131 900
Free-Float 99,7%
Chart INTEL CORPORATION
Duration : Period :
Intel Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INTEL CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 41
Last Close Price 29,07 $
Average target price 27,95 $
Spread / Average Target -3,85%
EPS Revisions
Managers and Directors
Patrick P. Gelsinger Chief Executive Officer & Director
David A. Zinsner Chief Financial Officer & Executive Vice President
Frank D. Yeary Independent Chairman
Daniel J. McKeon Vice President-Information Technology Group
Archana Deskus Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
INTEL CORPORATION9.99%120 263
NVIDIA CORPORATION43.31%515 407
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED18.17%460 915
BROADCOM INC.7.80%251 881
TEXAS INSTRUMENTS7.26%164 983
QUALCOMM, INC.25.94%155 214